Franklin Biotechnology Valuation
| FBTDX Fund | USD 119.17 0.64 0.53% |
At this time, the entity appears to be overvalued. Franklin Biotechnology shows a prevailing Real Value of $117.12 per share. The current price of the fund is $119.17. We determine the value of Franklin Biotechnology from reviewing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we advise acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will submerge.
Overvalued
Today
Please note that Franklin Biotechnology's price fluctuation is very steady at this time. At this time, the entity appears to be overvalued. Franklin Biotechnology shows a prevailing Real Value of $117.12 per share. The current price of the fund is $119.17. We determine the value of Franklin Biotechnology from reviewing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we advise acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will submerge.
Our valuation method for Franklin Biotechnology Discovery is useful when determining the fair value of the Franklin mutual fund, which is usually determined by what a typical buyer is willing to pay for full or partial control of Franklin Biotechnology. Since Franklin Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Franklin Mutual Fund. However, Franklin Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 119.17 | Real 117.12 | Hype 119.81 |
The real value of Franklin Mutual Fund, also known as its intrinsic value, is the underlying worth of Franklin Biotechnology Mutual Fund, which is reflected in its stock price. It is based on Franklin Biotechnology's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Franklin Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Franklin Biotechnology's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Franklin Biotechnology Discovery helps investors to forecast how Franklin mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Franklin Biotechnology more accurately as focusing exclusively on Franklin Biotechnology's fundamentals will not take into account other important factors: Franklin Biotechnology Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Franklin Biotechnology's current stock value. Our valuation model uses many indicators to compare Franklin Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Franklin Biotechnology competition to find correlations between indicators driving Franklin Biotechnology's intrinsic value. More Info.Franklin Biotechnology Discovery is rated # 3 fund in price to earning among similar funds. It is one of the top funds in price to book among similar funds fabricating about 0.23 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Franklin Biotechnology Discovery is roughly 4.37 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Franklin Biotechnology by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Franklin Biotechnology's Mutual Fund. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Franklin Biotechnology's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Franklin Biotechnology's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Franklin Biotechnology and how it compares across the competition.
About Franklin Biotechnology Valuation
The fund valuation mechanism determines the current worth of Franklin Biotechnology Discovery on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Franklin Biotechnology Discovery. In general, an absolute valuation paradigm, as applied to this mutual fund, attempts to find the value of Franklin Biotechnology based exclusively on its fundamental and basic technical indicators. By analyzing Franklin Biotechnology's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Franklin Biotechnology's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Franklin Biotechnology. We calculate exposure to Franklin Biotechnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Franklin Biotechnology's related companies.Under normal market conditions, the fund invests at least 80 percent of its net assets in securities of biotechnology companies and discovery research firms. The fund predominantly invests in equity securities. In addition to its investments in biotechnology companies, the fund may also invest up to 20 percent of its net assets in equity or debt securities of any type of issuer. It is non-diversified.
8 Steps to conduct Franklin Biotechnology's Valuation Analysis
Mutual Fund's valuation is the process of determining the worth of any mutual fund in monetary terms. It estimates Franklin Biotechnology's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of mutual fund valuation is a single number representing a Mutual Fund's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Franklin Biotechnology's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Franklin Biotechnology's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Franklin Biotechnology's revenue streams: Identify Franklin Biotechnology's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Franklin Biotechnology's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Franklin Biotechnology's growth potential: Evaluate Franklin Biotechnology's management, business model, and growth potential.
- Determine Franklin Biotechnology's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Mutual Fund's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Franklin Biotechnology's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Franklin Biotechnology Discovery. Also, note that the market value of any mutual fund could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Franklin Biotechnology information on this page should be used as a complementary analysis to other Franklin Biotechnology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.